refs Hogg 2009

[michael edward badolato jr]

Refs
Hogg J.C. & vanEeden S.F. Pulmonary and systemic response to atmospheric pollution. Resp 14:336-46 2009
Lukacs N.W. Chemokines and their receptors in chronic pulmonary disease. Curr Drug Targ Inflam Aller 4:313-7 2004
Hiraiwa K. & vanEeden S.F. Nature and consequences of the systemic inflammatory response induced by lung inflammation. Provisional Chapter. Intech 2014
Heinrich J. & Assman G.Fibrinogen and cardiovascular risk. J Cardiovasc Risk 2;3:197-205 1995
Torres J.L. & Ridker P.M. Clinical use of high sensitivity c-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 18;6:471-8 2003
Goto Y. et al. Particulate matter air pollution stimulates monocyte release from the bone marrow. Am J Resp Crit Care Med 170:891-97 2004
Mukae H. et al. The effect of repeated exposure to particulate air pollution (PM-10) on the bone marrow. Am J Resp Crit Care Med 163:201-9 2001
Bernstein J.A. et al. Health effects of air pollution. J Aller Clin Immune 114;5:1116-23 2004
Fry et al. Regional deposition and clearance of particles in the human nose. J Aer Sc 3;113-4 1973
deHaar C. et al. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin Exp Aller 36;11:1469-79 2006
Oberdorster G. et al. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal Tox 8(s);73-89 1996
Pedata P. et al. Ultrafine particles and effects on the body: a review of the literature. G Ital Med Lav Ergon 32;1:23-31 2010
Valavanidis A. et al. Aoirborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidatve damaage and carcinogenic mechanisms. J Env Sc H C Env Carc Exotox Rev 26;4:339-62 2008